Concept
Immune Evasion
Future of Cancer Science | AACR Cancer Progress Report 2025 / Drug Development
"Recently, CRISPR screening has been used to identify novel immune-related targets that boost the effectiveness of chimeric antigen receptor (CAR) T-cell therapy and reveal mechanisms of immune evasion that tumors use to resist treatment, advancing the search for more effective immunotherapies (1069)Du Y, et al. (2025) Oncogene, 44:"
Related Ideas
- Immune ReprogrammingFuture of Cancer Science | AACR Cancer Progress Report 2025 · Next-Generation Treatments
- Targeted DeliveryFuture of Cancer Science | AACR Cancer Progress Report 2025 · Next-Generation Treatments
- Clinical TestingFuture of Cancer Science | AACR Cancer Progress Report 2025 · Next-Generation Treatments
- Precision EditingFuture of Cancer Science | AACR Cancer Progress Report 2025 · Basic Research Discoveries
- Target IdentificationFuture of Cancer Science | AACR Cancer Progress Report 2025 · Advancing New Treatments
- Immune ResponseFuture of Cancer Science | AACR Cancer Progress Report 2025 · Monitoring Treatment Response and Predicting Resistance
- Dynamic CtdnaFuture of Cancer Science | AACR Cancer Progress Report 2025 · Monitoring Treatment Response and Predicting Resistance
- Il-10 AgonismNature · Global conservation area coverage substantially exceeds current estimates